Resmed INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
RMD
Resmed INCAustralianSuper Pty Ltd has reported a beneficial ownership of 5.7% in ResMed Inc.'s ordinary shares as of June 30, 2026.
NYSE
RMD
Resmed INCSCHEDULE: ResMed Inc. Discloses Nyxoah SA Stake
ResMed Inc. has filed a Schedule 13G, reporting beneficial ownership of 1,943,828 ordinary shares in Nyxoah SA, representing 1.95% of the outstanding shares.
NYSE
RMD
Resmed INCSCHEDULE: Vanguard Discloses 5.41% Stake in ResMed
Vanguard Portfolio Management has reported beneficial ownership of 7,886,489 shares, representing 5.41% of ResMed Inc.'s common stock, as of March 31, 2026.
NYSE
RMD
Resmed INCSCHEDULE: Vanguard Discloses 8.2% Stake in ResMed
Vanguard Capital Management has reported beneficial ownership of 11,961,706 shares, representing 8.2% of ResMed Inc.'s common stock as of March 31, 2026.
NYSE
RMD
Resmed INCThe Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in ResMed Inc. following an internal realignment.
NYSE
RMD
Resmed INCThe Vanguard Group has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 13.66% in ResMed Inc. as of September 30, 2025.